You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (32) |
Back to Search
Analysis of influence factors of severe neutropenia induced by etoposide-based chemotherapy
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-HPS-052
- By: ZHU, Yu (Chinese People's Liberation Army General Hospital, China)
- Co-author(s): Yu Zhu: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Daihong Guo: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Chong Yao: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Hongyi Yang: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Chengxuan Yu: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Siyuan Liu: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China
Xianghao Kong: Pharmacy Department, Medical Security Center, Chinese People's Liberation Army General Hospital, Beijing, China - Abstract:
Background
Etoposide is a widely used antineoplastic drug, however, it can induce neutropenia which may compromise optimal cancer management. In addition, there has not much research on influence factors of severe neutropenia induced by etoposide-based chemotherapy (SNIEC).
Purpose
The aim of this study is to investigate the influence factors and
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026